Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Preservation group sues Trump administration over White House...
House GOP unveils healthcare plan ahead of vote...
Cruz says Rep Ilhan Omar could face jail...
Republican House leader signals plan to begin contempt...
MIKE DAVIS: Why DC’s Trump-hating Judge Boasberg must...
State Department stays quiet as Albania reinstates deputy...
Maduro trapped with few retaliation options after Trump...
Sun Summit Announces Upsized Non-Brokered Private Placement of...
InMed Provides Update on BayMedica Commercial Business
Contango ORE, Dolly Varden Announce Strategic Silver Merger
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

You may also like

SAGA Metals Completes IPO with Focus on Uranium...

September 25, 2024

Trading Halt

December 6, 2024

CSE Bulletin: Name Change – Tisdale Clean Energy...

October 1, 2024

Radisson Mining Resources

January 20, 2025

Lac Carheil Graphite Project Awarded Grant Funding

March 6, 2025

Biggest Canadian Defense Contractors and ETFs in 2025

July 17, 2025

Heritage Mining Zone 3 Successful SGH Soil Survey

July 25, 2024

Anteros Metals: Science-based, Diversified Mineral Exploration in Eastern...

February 4, 2025

Trump’s Big Beautiful Bill to Rewrite America’s Energy,...

July 8, 2025

Crypto Market Recap: Cryptos Rally as Trump’s Big...

July 9, 2025

Recent Posts

  • Preservation group sues Trump administration over White House ballroom project
  • House GOP unveils healthcare plan ahead of vote next week as cost hike looms for millions
  • Cruz says Rep Ilhan Omar could face jail time, deportation if marriage allegation proves true
  • Republican House leader signals plan to begin contempt proceedings against Bill and Hillary Clinton
  • MIKE DAVIS: Why DC’s Trump-hating Judge Boasberg must be impeached

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (963)
    • Investing (3,656)
    • Politics (4,414)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.